Johnson & Johnson
Johnson & Johnson is a multinational corporation based in the United States that develops medical devices, pharmaceuticals, and consumer packaged goods. It is renowned for its commitment to quality and has a long-standing history of increasing dividends, making it a staple in many investment portfolios.
Not in the pool (under ¢1).
Recent news mentions
Johnson & Johnson is positioned well with a novel cancer drug expected to generate high revenues.
Novo Nordisk und Eli Lilly dominieren wohl noch Jahre
Switzerland· 2025-06-25
Johnson & Johnson is among the American companies that have announced nearly $250 billion in investments in the United States.
Sanofi promet d’investir 20 milliards de dollars aux Etats-Unis
France· 2025-05-14
Johnson & Johnson is said to generate 15 percent of the economic output of the northeastern Swiss canton with its large filling plant.
US-Zölle auf Medikamente: Schweiz drohen ProduktionsverlagerungenSwitzerland· 2025-03-22
Johnson & Johnson is one of the companies in which the fund is invested.
«Microsoft weist eine aussergewöhnliche Vorhersehbarkeit auf»Switzerland· 2025-03-20
Johnson & Johnson has a record of raising its dividend more than 60 times in a row.
Dividenden als Rendite-Booster: Ausschüttungen treiben BörsenkurseSwitzerland· 2025-03-01
